{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:09:47Z","timestamp":1792271387842,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.biocel.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T13:31:03Z","timestamp":1392471063000},"page":"180-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Cystic fibrosis: Evidence for gut inflammation"],"prefix":"10.1016","volume":"52","author":[{"given":"Anne","family":"Munck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biocel.2014.02.005_bib0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1172\/JCI116966","article-title":"Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization","volume":"93","author":"Strong","year":"1994","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.biocel.2014.02.005_bib0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"issue":"4","key":"10.1016\/j.biocel.2014.02.005_bib0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1152\/ajpgi.2001.281.4.G899","article-title":"Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse","volume":"281","author":"De Lisle","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.biocel.2014.02.005_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2006-0184TR","article-title":"Cystic fibrosis mouse models","volume":"36","author":"Guilbault","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"September (9)","key":"10.1016\/j.biocel.2014.02.005_bib0025","first-page":"a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"De Lisle","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.biocel.2014.02.005_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1152\/ajpgi.00491.2005","article-title":"Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression","volume":"291","author":"Malmberg","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2982.2009.01418.x","article-title":"Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine","volume":"22","author":"De Lisle","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"10.1016\/j.biocel.2014.02.005_bib0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/MPG.0b013e31817e0f2c","article-title":"Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine","volume":"47","author":"De Lisle","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.biocel.2014.02.005_bib0045","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1128\/IAI.72.10.6040-6049.2004","article-title":"Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine","volume":"72","author":"Norkina","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.biocel.2014.02.005_bib0050","doi-asserted-by":"crossref","first-page":"G104","DOI":"10.1152\/ajpgi.00548.2006","article-title":"Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine","volume":"293","author":"De Lisle","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.biocel.2014.02.005_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/gmic.22430","article-title":"Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota","volume":"4","author":"Lynch","year":"2013","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.biocel.2014.02.005_bib0060","doi-asserted-by":"crossref","first-page":"G381","DOI":"10.1152\/ajpgi.00003.2010","article-title":"Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice","volume":"299","author":"Canale-Zambrano","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"10.1016\/j.biocel.2014.02.005_bib0065","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1128\/IAI.68.4.2142-2147.2000","article-title":"Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis","volume":"68","author":"Yu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.biocel.2014.02.005_bib0070","doi-asserted-by":"crossref","first-page":"G1032","DOI":"10.1152\/ajpgi.00473.2003","article-title":"Inflammatin of the cystic fibrosis mouse small intestine","volume":"286","author":"Norkina","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.biocel.2014.02.005_bib0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-065X.2001.790107.x","article-title":"Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress","volume":"179","author":"Yu","year":"2001","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.biocel.2014.02.005_bib0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcp.20020","article-title":"Decreased expression of peroxisome proliferator activated receptor gamma in cftr\u2212\/\u2212 mice","volume":"200","author":"Ollero","year":"2004","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0085","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1203\/00006450-200003000-00010","article-title":"Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients","volume":"47","author":"Raia","year":"2000","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.biocel.2014.02.005_bib0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/adc.82.5.394","article-title":"Intestinal inflammation in cystic fibrosis","volume":"82","author":"Smyth","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.biocel.2014.02.005_bib0095","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1128\/AEM.05933-11","article-title":"Cross-sectional and longitudinal comparison of the predominant fecal microbiota composition between a group of pediatric patients with cystic fibrosis and their healthy siblings","volume":"77","author":"Duytschaever","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","article-title":"Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of intestinal inflammation in patients with cystic fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.biocel.2014.02.005_bib0110","doi-asserted-by":"crossref","first-page":"948367","DOI":"10.1155\/2012\/948367","article-title":"Update of faecal markers of inflammation in children with cystic fibrosis","volume":"2012","author":"Lee","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"7","key":"10.1016\/j.biocel.2014.02.005_bib0115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.biocel.2014.02.005_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.mpg.0000189322.34582.3e","article-title":"Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation","volume":"42","author":"De Lisle","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.biocel.2014.02.005_bib0125","first-page":"612","article-title":"Increased survival of CFTR knockout mice with an oral osmotic laxative","volume":"46","author":"Clarke","year":"1996","journal-title":"Lab Anim Sci"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0130","doi-asserted-by":"crossref","first-page":"G577","DOI":"10.1152\/ajpgi.00195.2007","article-title":"Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine","volume":"293","author":"De Lisle","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.biocel.2014.02.005_bib0135","doi-asserted-by":"crossref","first-page":"C1173","DOI":"10.1152\/ajpcell.00528.2003","article-title":"SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents","volume":"287","author":"Cuppoletti","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.biocel.2014.02.005_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-230X-10-107","article-title":"Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype","volume":"10","author":"De Lisle","year":"2010","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0145","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2009.05.037","article-title":"Activation of intestinal Cl\u2212 secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator","volume":"137","author":"Bijvelds","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biocel.2014.02.005_bib0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clnu.2007.01.004","article-title":"Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study","volume":"26","author":"Bruzzese","year":"2007","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.biocel.2014.02.005_bib0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ppul.21138","article-title":"Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study","volume":"45","author":"Weiss","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl.","key":"10.1016\/j.biocel.2014.02.005_bib0160","first-page":"S125","volume":"36","author":"Freedman","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"7381","key":"10.1016\/j.biocel.2014.02.005_bib0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727251400048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727251400048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:54:26Z","timestamp":1761202466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135727251400048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"alternative-id":["S135727251400048X"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2014.02.005","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis: Evidence for gut inflammation","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}